BL Riggs, LC Hartmann - New England Journal of Medicine, 2003 - content.nejm.org The selective estrogen-receptor modulators (SERMs) represent a major therapeutic
advance for clinical practice. Unlike estrogens, which are uniformly agonists,
and antiestrogens, which are uniformly antagonists, the SERMs exert ... Cited by 374 - Related articles - BL Direct - All 7 versions
- ►uvm.edu [PDF] F Grodstein, TB Clarkson, JAE Manson - The New England journal of medicine, 2003 - nejm.highwire.org Recent findings from clinical trials examining the relation between
postmenopausal hormone therapy and coronary heart disease 1 , 2 have appeared to
be widely divergent from the results of earlier observational studies. In ... Cited by 258 - Related articles - BL Direct - All 6 versions
- ►annals.org AM Kanaya, D Herrington, E Vittinghoff, F Lin, … - Annals of internal medicine, 2003 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Randomized trials of postmenopausal hormone therapy have found ... Cited by 191 - Related articles - BL Direct - All 7 versions
HN Hodis, WJ Mack, SP Azen, RA Lobo, D … - New England Journal of Medicine, 2003 - content.nejm.org From the Atherosclerosis Research Unit, Keck School of Medicine (HNH, WJM, SPA,
AS, ABS, RHS), the Department of Preventive Medicine (HNH, WJM, SPA, MT), the
Department of Molecular Pharmacology and Toxicology, School of Pharmacy ... Cited by 193 - Related articles - BL Direct - All 9 versions
- ►ahajournals.org DM Herrington, TD Howard, KB Brosnihan, DP … - Circulation, 2002 - Am Heart Assoc Methods and Results— Serum levels of soluble E-selectin and CRP were measured
at baseline and 1 year in 264 postmenopausal women randomized to treatment with
oral conjugated equine estrogen (0.625 mg/d), estrogen plus progestin ( ... Cited by 166 - Related articles - All 8 versions
- ►ahajournals.org ML Bots, GW Evans, WA Riley, DE Grobbee - Stroke, 2003 - Am Heart Assoc Summary of Comment— To estimate the average CIMT progression rate, we
performed a pooled analysis using CIMT progression rates of control groups from
published RCTs. The pros and cons of the following ultrasound options are ... Cited by 149 - Related articles - BL Direct - All 4 versions
SM Harman, EA Brinton, M Cedars, R Lobo, JE … - Climacteric, 2005 - informahealthcare.com Kronos Longevity Research Institute, Phoenix, Arizona; *Metabolism Section,
Cardiovascular Genetics, University of Utah, Salt Lake City, Utah; { Department
of Obstetrics and Gynecology, University of California at San Francisco, ... Cited by 148 - Related articles - All 7 versions
- ►nih.gov [PDF] SR Salpeter, JME Walsh, E Greyber, TM … - Journal of General Internal Medicine, 2004 - Springer EMBASE databases was performed to identify randomized con- trolled trials of
hormone replacement therapy from 1966 to September 2002. The search was
augmented by scanning selected journals through April 2003 and references ... Cited by 130 - Related articles - BL Direct - All 15 versions
KL Margolis, DE Bonds, RJ Rodabough, L … - Diabetologia, 2004 - Springer Aims/hypothesis. Studies examining the effect of postmenopausal hormone therapy
on concentrations of glucose, insulin and diabetes incidence have been
inconclusive, in part because many of the studies were too small. We ... Cited by 124 - Related articles - BL Direct - All 3 versions
- ►oxfordjournals.org RL Prentice, R Langer, ML Stefanick, BV … - American journal of epidemiology, 2005 - Oxford Univ Press Observational research on postmenopausal hormone therapy suggests a 40–50%
reduction in coronary heart disease incidence among women using these
preparations. In contrast, the Women's Health Initiative clinical trial of ... Cited by 99 - Related articles - BL Direct - All 11 versions
